CANCER HOPE: New drug could extend lives of patients with untreatable tumours

CANCER HOPE: New drug could extend lives of patients with untreatable tumours
 

Drug Nivolumab extended the lives of those whose cancer relapsed and no “existing treatment options” were available.
More than one in three people given the treatment during a trial were still alive after a year, compared to just 17 per cent who received chemotherapy.
And researchers said the Phase III study, the final clinical stage before a new treatment is licensed, provided breakthrough evidence of a drug improving survival rates among this group of patients.
Professor Kevin Harrington, from The Institute of Cancer Research, London, who led the British arm of the international trial,... read more

 
11 October 2016 in Health, Views: 41
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31